Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Asset Utilization Ratio (2016 - 2021)

Historic Asset Utilization Ratio for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q1 2021 value amounting to 0.03.

  • Avadel Pharmaceuticals' Asset Utilization Ratio fell 8910.46% to 0.03 in Q1 2021 from the same period last year, while for Mar 2021 it was 0.03, marking a year-over-year decrease of 8910.46%. This contributed to the annual value of 0.1 for FY2020, which is 7216.6% down from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Asset Utilization Ratio stood at 0.03 for Q1 2021, which was down 8910.46% from 0.07 recorded in Q4 2020.
  • Avadel Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.68 for Q3 2017, and its period low was 0.03 during Q1 2021.
  • In the last 5 years, Avadel Pharmaceuticals' Asset Utilization Ratio had a median value of 0.43 in 2019 and averaged 0.4.
  • In the last 5 years, Avadel Pharmaceuticals' Asset Utilization Ratio surged by 12691.17% in 2017 and then crashed by 8910.46% in 2021.
  • Avadel Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.66 in 2017, then crashed by 31.44% to 0.45 in 2018, then decreased by 14.3% to 0.39 in 2019, then tumbled by 81.87% to 0.07 in 2020, then crashed by 52.22% to 0.03 in 2021.
  • Its Asset Utilization Ratio stands at 0.03 for Q1 2021, versus 0.07 for Q4 2020 and 0.1 for Q3 2020.